-
GH Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Guardant Health (GH)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 629.76 mm | 629.76 mm | 629.76 mm | 629.76 mm | 629.76 mm | 629.76 mm |
Cash burn (monthly) | 19.54 mm | 41.99 mm | 41.99 mm | 38.36 mm | 21.50 mm | 19.99 mm |
Cash used (since last report) | 48.63 mm | 104.52 mm | 104.50 mm | 95.48 mm | 53.52 mm | 49.75 mm |
Cash remaining | 581.13 mm | 525.24 mm | 525.25 mm | 534.27 mm | 576.23 mm | 580.01 mm |
Runway (months of cash) | 29.7 | 12.5 | 12.5 | 13.9 | 26.8 | 29.0 |
13F holders | Current |
---|---|
Total holders | 301 |
Opened positions | 62 |
Closed positions | 36 |
Increased positions | 94 |
Reduced positions | 88 |
13F shares | Current |
---|---|
Total value | 3.62 tn |
Total shares | 122.76 mm |
Total puts | 1.78 mm |
Total calls | 758.40 k |
Total put/call ratio | 2.3 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 12.05 mm | $368.21 bn |
BlackRock | 11.70 mm | $357.48 bn |
Deep Track Capital | 6.42 mm | $196.12 bn |
Baillie Gifford & Co | 5.45 mm | $166.47 bn |
Cadian Capital Management | 5.22 mm | $159.52 bn |
Wellington Management | 4.85 mm | $148.18 bn |
Capital International Investors | 4.47 mm | $136.66 bn |
Eventide Asset Managment | 3.81 mm | $116.33 bn |
STT State Street | 2.85 mm | $87.04 bn |
Braidwell | 2.85 mm | $87.00 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Mar 25 | Michael Brian Bell | RSU Common Stock | Grant | Acquire A | No | No | 0 | 22,332 | 0.00 | 22,332 |
12 Mar 25 | Michael Brian Bell | Stock Option Common Stock | Grant | Acquire A | No | No | 43.1 | 33,498 | 1.44 mm | 33,498 |
12 Mar 25 | Darya Chudova | RSU Common Stock | Grant | Acquire A | No | No | 0 | 20,302 | 0.00 | 20,302 |
12 Mar 25 | Darya Chudova | Stock Option Common Stock | Grant | Acquire A | No | No | 43.1 | 30,453 | 1.31 mm | 30,453 |
12 Mar 25 | Craig Eagle | RSU Common Stock | Grant | Acquire A | No | No | 0 | 16,242 | 0.00 | 16,242 |
12 Mar 25 | Craig Eagle | Stock Option Common Stock | Grant | Acquire A | No | No | 43.1 | 24,363 | 1.05 mm | 24,363 |
12 Mar 25 | Helmy Eltoukhy | RSU Common Stock | Grant | Acquire A | No | No | 0 | 116,010 | 0.00 | 116,010 |
12 Mar 25 | Helmy Eltoukhy | RSU Common Stock | Grant | Acquire A | No | No | 0 | 19,258 | 0.00 | 19,258 |
12 Mar 25 | Chris Freeman | RSU Common Stock | Grant | Acquire A | No | No | 0 | 15,430 | 0.00 | 15,430 |
12 Mar 25 | Chris Freeman | Stock Option Common Stock | Grant | Acquire A | No | No | 43.1 | 23,145 | 997.55 k | 23,145 |